Publications: Early detection of recurrence

Early detection of recurrence


The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study.

Rolff HC, Christensen IJ, Svendsen LB, Wilhelmsen M, Lund IK, Thurison T, Høyer-Hansen G, Illemann M, Nielsen HJ

Journal of surgical oncology (2019 Dec)
Issue 8 p. 1404-1411 issn:1096-9098


Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma:
Risk of subsequent primary malignancy?   

Piper TB, Jørgensen LN, Olsen J, Nielsen KT, Davis G, Johansen JS,Jarle Christensen I, Nielsen HJ

Acta Oncol. 2019 58(sup1):S42-S48. doi: 10.1080/0284186X.2018.1540885.
Epub 2018 Dec 7.


Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer.

Schøler LV, Reinert T, Ørntoft MW, Kassentoft CG, Árnadóttir SS, Vang S, Nordentoft I, Knudsen M, Lamy P, Andreasen D, Mortensen FV, Knudsen AR, Stribolt K, Sivesgaard K, Mouritzen P, Nielsen HJ, Laurberg S, Ørntoft TF, Andersen CL

Clinical cancer research : an official journal of the American Association for Cancer Research (2017 Jun)


The prognostic and predictive value of soluble of type IV collagen in colorectal cancer: A retrospective multicenter study.

To investigate the prognostic and predictive biomarker value of type IV collagen in colorectal cancer (CRC).

Rolff HC, Christensen IJ, Vainer B, Svendsen LB, Loevendahl Eefsen R, Wilhelmsen M, Lund IK, Hoyer-Hansen G, Nielsen HJ, Illemann M

Clinical cancer research : an official journal of the American Association for Cancer Research (2015 Dec) issn:1078-0432)


Determinants of recurrence after intended curative resection for colorectal cancer.

Wilhelmsen M, Kring T, Jorgensen LN, Madsen MR, Jess P, Bulut O, Nielsen KT, Andersen CL, Nielsen HJ

Scandinavian journal of gastroenterology (2014 Dec) Issue 12 p. 1399-408 issn:1502-7708)


Localization of active, dually phosphorylated extracellular signal-regulated kinase 1 and 2 in colorectal cancer with or without activating BRAF and KRAS mutations.

Holck S, Bonde J, Pedersen H, Petersen AA, Chaube A, Nielsen HJ, Larsson LI

Hum Pathol. 2016 Aug;54:37-46. doi: 10.1016/j.humpath.2016.03.001. Epub 2016 Mar 29.


Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

Reinert T, Schøler LV, Thomsen R, Tobiasen H, Vang S, Nordentoft I, Lamy P, Kannerup AS, Mortensen FV, Stribolt K, Hamilton-Dutoit S, Nielsen HJ, Laurberg S, Pallisgaard N, Pedersen JS, Ørntoft TF, Andersen CL.

Gut. 2015 Feb 4. pii: gutjnl-2014-308859. doi: 10.1136/gutjnl-2014-308859. [Epub ahead of print


Circulating intact and cleaved forms of the urokinase-type plasminogen activator receptor: biological variation, reference intervals and clinical useful cut-points.

Thurison T, Christensen IJ, Lund IK, Nielsen HJ, Høyer-Hansen G.

Clin Chim Acta. 2015 Jan 15;439:84-90. doi: 10.1016/j.cca.2014.10.004. Epub 2014 Oct 13



Print Friendly, PDF & Email


ColoRectal Cancer Research

Gastroenheden, Hvidovre Hospital

Kettegård Allé 30

2650 Hvidovre